The latest CDC numbers show a 5.37% increase of measles cases from week-to-week. In Pennsylvania, the fourth measles-related death was reported in 2026. Additionally, the CDC has made a change in the way it will report deaths.
|Articles|March 7, 2020
Recalls That Should Be on Your Radar—Week of March 1, 2020
Author(s)Contagion® Editorial Staff
We’ve compiled a list of recalls issued by the US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) from this past week:
Advertisement
We’ve compiled a list of recalls issued by the US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) from this past week:
Hikma Pharmaceuticals USA Extends Recall of Ketorolac Tromethamine Injection Vials Due to Possible Presence of Small Particulates
Hikma Pharmaceuticals is voluntarily extending a previously announced recall of certain lots of Ketorolac Tomethamine Injection USP 30mg/mL, 1mL fill/2mL vials. Small visible particulate matters of a gelatinous or oily nature have been found in some of the recalled lots.
The recall was initiated on December 23, 2019. The recall has been extended to the medical facility and recall levels.
Use of the impacted product could result in particulates entering the lungs of patients, which could lead to multiple pulmonary microemboli with subsequent acute respiratory distress.
There have not been any adverse reports to date.
Read the
Becton Dickinson CareFusion 303 Issues Recall of Alaris System Infusion Pumps Due to Software and Symptom Errors
Becton Dickinson CareFusion 303 has issued a recall of the Alaris System infusion pump system and modules due to multiple system errors, use-related errors, and software errors.
Modules running on software version 9.33 or earlier may have low battery alarm failures, issues with delay options programming, and use related errors related to custom concentration programming.
Modules running on software version 12.1.0 may have low battery alarm failures, use related errors related to custom concentration programming, and the KVO rate not being available when using delay options programming.
The errors can lead to interruptions or delays in infusion as well as slower or faster delivery of medication than intended. There have been serious health adverse events. One death and 55 injuries have been reported.
Read the
Advertisement
Related to this article
A "Clinician Outreach" from the Centers for Disease Control and Prevention (CDC) in April anticipated an increase in rabies exposures, and the striking surge in case reports this summer prompted a recent health advisory alert from the federal agency.
Reported cases of Legionnaires’ disease have been on the rise for the past decade, and identifying Legionella bacteria requires specialized testing in the microbiology lab. Here is a clinical overview of Legionella bacteria, including required testing, treatment, and reporting to public health officials.
A retrospective multihospital study found that severe adverse events occurred at similarly low rates with ceftriaxone and other IV cephalosporins suggesting there is no evidence to support avoiding ceftriaxone despite recent health department safety alerts.
The 18-year old resident of the state suffered from acute disseminated encephalomyelitis. Pennsylvania numbers are surging with some of the highest state totals of measles cases in the country.
In its second disease cluster this summer, city officials are cleaning building towers in the South Bronx amidst an ongoing investigation and are rolling out measures to prevent future Legionnaires' cases.
New gyrA testing guides ciprofloxacin use for gonorrhea, cutting ceftriaxone reliance while tackling resistance, access, and FDA hurdles.
16 years after the FDA determined that it does not, a new analysis of trials comparing cefepime with other ß-lactams, including the unpublished industry sponsored trials reviewed by the FDA, disagrees.
Advertisement
Advertisement